105
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The Prognostic Value of Faciogenital Dysplasias As Biomarkers in Head and Neck Squamous Cell Carcinoma

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1399-1415 | Received 27 Jun 2019, Accepted 11 Sep 2019, Published online: 09 Oct 2019

References

  • Parkin DM , BrayF, FerlayJ, PisaniP. Global Cancer Statistics, 2002. CA Cancer J. Clin.55(2), 74–108 (2005).
  • Gatta G , BottaL, SanchezMJet al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study. Eur. J. Cancer51(15), 2130–2143 (2015).
  • Rahman S , KraljevicPavelic S, Markova-CarE. Circadian (de)regulation in head and neck squamous cell carcinoma. Int. J. Mol. Sci.20(11), (2019).
  • Budach V , TinhoferI. Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. Lancet Oncol.20(6), e313–e326 (2019).
  • Riva G , PecorariG, BiolattiMet al. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. Mol. Biol. Rep.46(3), 3333–3347 (2019).
  • Huber C , MartenssonA, BokochGM, NemazeeD, GavinAL. FGD2, a CDC42-specific exchange factor expressed by antigen-presenting cells, localizes to early endosomes and active membrane ruffles. J. Biol. Chem.283(49), 34002–34012 (2008).
  • Rossman KL , DerCJ, SondekJ. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol.6(2), 167–180 (2005).
  • Volter C , MartinezR, HagenR, KressW. Aarskog-Scott syndrome: a novel mutation in the FGD1 gene associated with severe craniofacial dysplasia. Eur. J. Pediatr.173(10), 1373–1376 (2014).
  • Ayala I , GiacchettiG, CaldieriGet al. Faciogenital dysplasia protein FGD1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer. Cancer Res.69(3), 747–752 (2009).
  • Beasley S , BuckhaultsPJ, PedigoNG, FarrellCL. Association of FGD1 polymorphisms with early-onset breast cancer. Oncol. Lett.12(3), 2071–2077 (2016).
  • Valla M , MjonesPG, EngstromMJet al. Characterization of FGD5 expression in primary breast cancers and lymph node metastases. J. Histochem. Cytochem.66(11), 787–799 (2018).
  • Valla M , EngstromMJ, YtterhusBet al. FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis. Breast Cancer Res. Treat.162(2), 243–253 (2017).
  • Catimel B , KappE, YinMXet al. The PI(3)P interactome from a colon cancer cell. J. Proteomics82, 35–51 (2013).
  • Hornbeck PV , ZhangB, MurrayB, KornhauserJM, LathamV, SkrzypekE. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res.43(Database issue), D512–520 (2015).
  • Sjoblom T , JonesS, WoodLDet al. The consensus coding sequences of human breast and colorectal cancers. Science314(5797), 268–274 (2006).
  • Cerami E , GaoJ, DogrusozUet al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov.2(5), 401–404 (2012).
  • Gao J , AksoyBA, DogrusozUet al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal.6(269), pl1–pl1 (2013).
  • J A . OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput. Sci.2, e67 (2016).
  • Carithers LJ , ArdlieK, BarcusMet al. A novel approach to high-quality postmortem tissue procurement: the GTEx project. Biopreserv. Biobank13(5), 311–319 (2015).
  • Huang Da W , ShermanBT, LempickiRA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res.37(1), 1–13 (2009).
  • Huang Da W , ShermanBT, LempickiRA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc.4(1), 44–57 (2009).
  • Tang Z , LiC, KangB, GaoG, LiC, ZhangZ. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res.45(W1), W98–W102 (2017).
  • Szklarczyk D , GableAL, LyonDet al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res.47(D1), D607–D613 (2019).
  • Maere S , HeymansK, KuiperM. BiNGO: a cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks. Bioinformatics21(16), 3448–3449 (2005).
  • Warde-Farley D , DonaldsonSL, ComesOet al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res.38(Web Server issue), W214–220 (2010).
  • Eitzen G , SmithersCC, MurrayAG, OverduinM. Structure and function of the Fgd family of divergent FYVE domain proteins (1). Biochem. Cell Biol.97(3), 257–264 (2019).
  • Genot E , DaubonT, SorrentinoV, BuccioneR. FGD1 as a central regulator of extracellular matrix remodelling – lessons from faciogenital dysplasia. J. Cell Sci.125(Pt 14), 3265–3270 (2012).
  • Garrett WS , ChenLM, KroschewskiRet al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell192, 235–334 (2000).
  • Hayakawa M , MatsushimaM, HagiwaraHet al. Novel insights into FGD3, a putative GEF for Cdc42, that undergoes SCF(FWD1/beta-TrCP)-mediated proteasomal degradation analogous to that of its homologue FGD1 but regulates cell morphology and motility differently from FGD1. Genes Cells13(4), 329–342 (2008).
  • Harrington WA , KimJY, YoonSO. Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. J. Neurosci.22(1), 156–166 (2002).
  • Hinz A , HerzbergPY, LordickFet al. Age and gender differences in anxiety and depression in cancer patients compared with the general population. Eur. J. Cancer Care (Engl.)e13129 (2019).
  • Tan S , DuongDinh TA, WesthofenM. Evaluation of gender-specific aspects in quality-of-life in patients with larynx carcinoma. Acta Otolaryngol.136(12), 1201–1205 (2016).
  • Meza R , MeernikC, JeonJ, CoteML. Lung cancer incidence trends by gender, race and histology in the United States, 1973–2010. PLoS One10(3), e0121323 (2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.